These results indicate that this dietary regimen may be more effective in regulation of HDAC1 expression and histone acetylation in breast cancer MDA-MB-231 cells than MDA-MB-157 cells, which shows a differential cellular response to this combination treatment. The gene discussed is HDAC1; the disease is breast carcinoma.